glp 1 dangerous Deceptive information and online sales of compounded GLP-1 drugs put consumers at risk, advocates say Pop a pill to lose

While that study did not report runaway tumor growth either, the lack of a spectacular reduction in tumor size, suggests BPC-157 offers no anti-cancer benefit and it leaves open the worry that it could even accelerate malignancy under the right conditions

Prescription DPP-4 inhibitors like sitagliptin extend GLP-1 half-life by blocking this enzyme, approximately doubling circulating GLP-1 levels

Ard J, Fitch A, Fruh S, Herman L

These are the most common symptoms of the medical complications we described above: Frequent nausea Excessive vomiting Acid reflux (GERD) Severe abdominal discomfort Bloating or swelling of the abdomen Loss of appetite Lack of bowel movements If you have experienced any of the symptoms listed above, seek immediate medical attention

doi: 10.1038/sj.bjp.0705805